Archive - March 2022

New Drugs

ViiV Healthcare Announces US FDA Approval of Cabenuva (cabotegravir, rilpivirine) for Virologically Suppressed Adolescents Living with HIV Who Are 12 Years of Age or Older and Weigh at Least 35 kg

3 years ago

Pharma Industry News

The marathoner approach to OEE

3 years ago

Pharma Industry News

Janssen shares new clinical trial data on its psoriasis treatment Tremfya

3 years ago

Pharma Industry News

Amgen shares new Otezla data at American Academy of Dermatology congress 2022

3 years ago

Pharma Industry News

Santen launches new educational eyecare site for patients in UK

3 years ago

Pharma Industry News

Google Cloud and Babylon Health collaborate to improve patient care

3 years ago

Healthcare News

Omicron Forces Shanghai To Impose Two-Part Lockdown

3 years ago

Healthcare News

COVID-19 Update: Omicron Subvariant More Severe For This Group Of People

3 years ago

Healthcare News

COVID-19 Update: Regulators Likely To Approve Second Booster Shot Soon

3 years ago

New Drugs

Fintepla (fenfluramine) Oral Solution Now FDA Approved for Treatment of Seizures Associated with Lennox-Gastaut Syndrome (LGS)

3 years ago